Immunosuppression drug advice and COVID-19: are we doing more harm than good?

Immunosuppression drug advice and COVID-19: are we doing more harm than good?
Br J Hosp Med (Lond). 2020 Jun 02;81(6):1-3
Authors: Warraich R, Amani L, Mediwake R, Tahir H
Abstract
The National Institute for Health and Care Excellence guidelines advise stopping immunosuppressive drugs for confirmed or suspected COVID-19 patients with autoimmune and inflammatory disorders. This may not be in the patient's best interest, given the potential long-term consequences of not managing chronic conditions, and immunosuppression may even be protective in those affected with COVID-19.
PMID: 32589546 [PubMed - as supplied by publisher]

Source: British Journal of Hospital Medicine - June 1, 2020 Category: Internal Medicine Authors: Warraich R, Amani L, Mediwake R, Tahir H Tags: Br J Hosp Med (Lond) Source Type: research